Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Fragmin (dalteparin sodium)
Locations
14
Canada
Queen Elizabeth II Health Science Centre
Halifax, Nova Scotia, Canada
Hamilton Health Science Centre - Hamilton General Hospital
Hamilton, Ontario, Canada
Hamilton Health Science Centre - McMaster University
Hamilton, Ontario, Canada
St Joseph's HealthCare
Hamilton, Ontario, Canada
Hamilton Health Science Centre - Henderson Hospital
Hamilton, Ontario, Canada
Ottawa General Hospital
Ottawa, Ontario, Canada
Start Date
July 1, 2004
Completion Date
June 1, 2006
Last Updated
June 1, 2007
NCT01524276
NCT07262333
NCT02769975
NCT06314503
NCT06659835
NCT06863194
Lead Sponsor
Hamilton Health Sciences Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions